My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 98

1.

A hypothesis-generating search for new genetic breast cancer syndromes--a national study in 803 Swedish families.

von Wachenfeldt A, Lindblom A; South Swedish Oncogenetic Study Group, Grönberg H, Einbeigi Z, Rosenquist R, Gardman C, Iselius L.

Hered Cancer Clin Pract. 2007 Mar 15;5(1):17-24.PMID: 19769788 [PubMed]Related articles

2.
3.

Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing.

Lorenzo Bermejo J, Hemminki K.

Ann Oncol. 2004 Dec;15(12):1834-41.PMID: 15550590 [PubMed - indexed for MEDLINE]Related articlesFree article

4.

The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusions.

Glimelius B, Bergh J, Brandt L, Brorsson B, Gunnars B, Hafström L, Haglund U, Högberg T, Janunger KG, Jönsson PE, Karlsson G, Kimby E, Lamnevik G, Nilsson S, Permert J, Ragnhammar P, Sörenson S, Nygren P.

Acta Oncol. 2001;40(2-3):135-54. Review.PMID: 11441927 [PubMed - indexed for MEDLINE]Related articles

5.

Increased risk of breast cancer in relatives of malignant melanoma patients from families with strong cancer familial aggregation.

Debniak T, Górski B, Cybulski C, Jakubowska A, Kurzawski G, Kładny J, Załuga E, Fiedorowicz J, Debniak B, Lubiński J.

Eur J Cancer Prev. 2003 Jun;12(3):241-5.PMID: 12771565 [PubMed - indexed for MEDLINE]Related articles

6.

Predisposing genes in breast and ovarian cancer: an overview.

Smith SA, Ponder BA.

Tumori. 1993 Oct 31;79(5):291-6. Review.PMID: 8116068 [PubMed - indexed for MEDLINE]Related articles

8.

[Risk assessment for familial occurrence of breast cancer]

Chang-Claude J, Becher H, Hamann U, Schroeder-Kurth T.

Zentralbl Gynakol. 1995;117(8):423-34. German. PMID: 7571905 [PubMed - indexed for MEDLINE]Related articles

9.

Risk of cancer in relatives of prostate cancer probands.

Isaacs SD, Kiemeney LA, Baffoe-Bonnie A, Beaty TH, Walsh PC.

J Natl Cancer Inst. 1995 Jul 5;87(13):991-6.PMID: 7629886 [PubMed - indexed for MEDLINE]Related articles

10.

German national case collection of familial pancreatic cancer - clinical-genetic analysis of the first 21 families.

Rieder H, Sina-Frey M, Ziegler A, Hahn SA, Przypadlo E, Kress R, Gerdes B, Colombo Benkmann M, Eberl T, Grützmann R, Lörken M, Schmidt J, Bartsch DK.

Onkologie. 2002 Jun;25(3):262-6.PMID: 12119461 [PubMed - indexed for MEDLINE]Related articles

11.

Cancer risk in families with hereditary prostate carcinoma.

Grönberg H, Bergh A, Damber JE, Emanuelsson M.

Cancer. 2000 Sep 15;89(6):1315-21.PMID: 11002228 [PubMed - indexed for MEDLINE]Related articlesFree article

12.

BRCA2 germline mutations in Swedish breast cancer families.

Chen J, Hedman MZ, Arver BW, Sigurdsson S, Eyfjörd JE, Lindblom A.

Eur J Hum Genet. 1998 Mar-Apr;6(2):134-9.PMID: 9781057 [PubMed - indexed for MEDLINE]Related articlesFree article

13.

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.

Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Måsbäck A, Westerdahl J, Olsson H, Ingvar C.

J Natl Cancer Inst. 2000 Aug 2;92(15):1260-6.PMID: 10922411 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

Familial association of pancreatic cancer with other malignancies in Swedish families.

Hiripi E, Lorenzo Bermejo J, Li X, Sundquist J, Hemminki K.

Br J Cancer. 2009 Nov 17;101(10):1792-7. Epub 2009 Oct 13.PMID: 19826425 [PubMed - indexed for MEDLINE]Related articles

15.

Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.

Cederquist K, Emanuelsson M, Wiklund F, Golovleva I, Palmqvist R, Grönberg H.

Clin Genet. 2005 Dec;68(6):533-41.PMID: 16283884 [PubMed - indexed for MEDLINE]Related articles

16.

Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel.

Rennert G, Dishon S, Rennert HS, Fares F.

Eur J Cancer Prev. 2005 Aug;14(4):357-61.PMID: 16030426 [PubMed - indexed for MEDLINE]Related articles

17.

Cancer in twins: genetic and nongenetic familial risk factors.

Ahlbom A, Lichtenstein P, Malmström H, Feychting M, Hemminki K, Pedersen NL.

J Natl Cancer Inst. 1997 Feb 19;89(4):287-93.PMID: 9048832 [PubMed - indexed for MEDLINE]Related articlesFree article

18.

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.

Eerola H, Heikkilä P, Tamminen A, Aittomäki K, Blomqvist C, Nevanlinna H.

Breast Cancer Res. 2005;7(1):R93-100. Epub 2004 Nov 19.PMID: 15642173 [PubMed - indexed for MEDLINE]Related articlesFree article

19.

Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.

Johannsson O, Ostermeyer EA, Håkansson S, Friedman LS, Johansson U, Sellberg G, Brøndum-Nielsen K, Sele V, Olsson H, King MC, Borg A.

Am J Hum Genet. 1996 Mar;58(3):441-50.PMID: 8644702 [PubMed - indexed for MEDLINE]Related articlesFree article

20.

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC.

JAMA. 2006 Mar 22;295(12):1379-88.PMID: 16551709 [PubMed - indexed for MEDLINE]Related articlesFree article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Write to the Help Desk